MétaCan
Menu
Back to cohort
Record W2952198271 · doi:10.1200/po.18.00325

Therapeutic Implication of Genomic Landscape of Adult Metastatic Sarcoma

2019· article· en· W2952198271 on OpenAlexafffund
Xiaolan Feng, Erin Pleasance, Eric Y. Stutheit-Zhao, Tony Ng, Jasleen Grewal, Nissreen Mohammad, Sara Taylor, Christine Simmons, Amirrtha Srikanthan, Shahrad R. Rassekh, Rebecca Deyell, Jennifer Rauw, Meg Knowling, Kong Khoo, Ursula Lee, Krista Noonan, Jason Hart, R. Petter Tonseth, Yaoqing Shen, Emma Titmuss, Martin Jones, Melika Bonakdar, Caralyn Reisle, Greg Taylor, Simon K. Chan, Karen Mungall, Eric Chuah, Andrew J. Mungall, Richard A. Moore, Howard J. Lim, Daniel J. Renouf, Karen A. Gelmon, Stephen Yip, Steven J.M. Jones, Marco A. Marra, Janessa Laskin

Bibliographic record

VenueJCO Precision Oncology · 2019
Typearticle
Languageen
FieldMedicine
TopicSarcoma Diagnosis and Treatment
Canadian institutionsBC Children's HospitalKelowna General HospitalUniversity of British Columbia
FundersCommon FundNational Institutes of HealthNational Cancer InstituteBC Cancer FoundationGenome British ColumbiaAmerican Society of Clinical Oncology
KeywordsSarcomaBiologyCopy-number variationCancer researchTranscriptomeCancerCarcinogenesisTrabectedinGenomeGeneMedicineGeneticsPathologySoft tissue sarcomaGene expression

Abstract

fetched live from OpenAlex

PURPOSE: This study investigated therapeutic potential of integrated genome and transcriptome profiling of metastatic sarcoma, a rare but extremely heterogeneous group of aggressive mesenchymal malignancies with few systemic therapeutic options. METHODS: Forty-three adult patients with advanced or metastatic non-GI stromal tumor sarcomas of various histology subtypes who were enrolled in the Personalized OncoGenomics program at BC Cancer were included in this study. Fresh tumor tissues along with blood samples underwent whole-genome and transcriptome sequencing. RESULTS: The most frequent genomic alterations in this cohort are large-scale structural variation and somatic copy number variation. Outlier RNA expression as well as somatic copy number variations, structural variations, and small mutations together suggest the presence of one or more potential therapeutic targets in the majority of patients in our cohort. Point mutations or deletions in known targetable cancer genes are rare; for example, tuberous sclerosis complex 2 provides a rationale for targeting the mammalian target of rapamycin pathway, resulting in a few patients with exceptional clinical benefit from everolimus. In addition, we observed recurrent 17p11-12 amplifications, which seem to be a sarcoma-specific event. This may suggest that this region harbors an oncogene(s) that is significant for sarcoma tumorigenesis. Furthermore, some sarcoma tumors carrying a distinct mutational signature suggestive of homologous recombination deficiency seem to demonstrate sensitivity to double-strand DNA-damaging agents. CONCLUSION: Integrated large-scale genomic analysis may provide insights into potential therapeutic targets as well as novel biologic features of metastatic sarcomas that could fuel future experimental and clinical research and help design biomarker-driven basket clinical trials for novel therapeutic strategies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.465
Threshold uncertainty score0.862

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.027
GPT teacher head0.338
Teacher spread0.311 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations21
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueJCO Precision OncologySame topicSarcoma Diagnosis and TreatmentFrench-language works237,207